JNJ WD — Johnson & Johnson Balance Sheet
0.000.00%
- $397.54bn
- $415.90bn
- $94.94bn
- 82
- 38
- 57
- 62
Annual balance sheet for Johnson & Johnson, fiscal year end - January 1st, USD millions except per share, conversion factor applied.
2018 December 30th | 2019 December 29th | 2021 January 3rd | 2022 January 2nd | 2023 January 1st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 19,687 | 19,287 | 25,185 | 31,608 | 23,519 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 14,098 | 14,481 | 13,576 | 15,283 | 16,160 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 46,033 | 45,274 | 51,237 | 60,979 | 55,294 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 17,035 | 18,615 | 19,766 | 19,862 | 20,903 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 152,954 | 157,728 | 174,894 | 182,018 | 187,378 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 31,230 | 35,964 | 42,493 | 45,226 | 55,802 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 93,202 | 98,257 | 111,616 | 107,995 | 110,574 |
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 59,752 | 59,471 | 63,278 | 74,023 | 76,804 |
| Total Liabilities & Shareholders' Equity | 152,954 | 157,728 | 174,894 | 182,018 | 187,378 |
| Total Common Shares Outstanding |